Export file:


  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text


  • Citation Only
  • Citation and Abstract

Epigenetic regulation in Autism spectrum disorder

Molecular and Behavioral Neuroscience Institute, University of Michigan, Ann Arbor, MI-48109, USA

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by an impaired social communication skill and often results in repetitive, stereotyped behavior which is observed in children during the first few years of life. Other characteristic of this disorder includes language disabilities, difficulties in sensory integration, lack of reciprocal interactions and in some cases, cognitive delays. One percentage of the general population is affected by ASD and is four times more common in boys than girls. There are hundreds of genes, which has been identified to be associated with ASD etiology. However it remains difficult to comprehend our understanding in defining the genetic architecture necessary for complete exposition of its pathophysiology. Seeing the complexity of the disease, it is important to adopt a multidisciplinary approach which should not only focus on the “genetics” of autism but also on epigenetics, transcriptomics, immune system disruption and environmental factors that could all impact the pathogenesis of the disease. As environmental factors also play a key role in regulating the trigger of ASD, the role of chromatin remodeling and DNA methylation has started to emerge. Such epigenetic modifications directly link molecular regulatory pathways and environmental factors, which might be able to explain some aspects of complex disorders like ASD. The present review will focus on the role of epigenetic regulation in defining the underlying cause for ASD
  Article Metrics

Keywords Autism; DNA methylation; histones; GABA; reelin

Citation: Sraboni Chaudhury. Epigenetic regulation in Autism spectrum disorder. AIMS Genetics, 2016, 3(4): 292-299. doi: 10.3934/genet.2016.4.292


  • 1. Kanner L (1944) Autistic disturbances of affective contact. Nerv Child 2: 217-250.
  • 2. Asperger H (1944) Die “autistischen Psychopathen” im Kindesalter. Arch Psychiatr Nervenkr 177: 76-137.
  • 3. Coleman M, Gillberg C (2012) The Autisms. Oxford University Press: USA 432 pp.
  • 4. Foxe JJ, Molholm S, Del Bene VA, et al. (2013) Severe multisensory speech integration deficits in high-functioning school-aged children with autism spectrum disorder (ASD) and their resolution during early adolescence. Cereb Cortex 25: 298-312.
  • 5. Marco EJ, Hinkley LB, Hill SS, et al. (2011) Sensory processing in autism: a review of neurophysiologic findings. Pediatr Res 69: 48-54.    
  • 6. Ming X, Brimacombe M, Wagner GC (2007) Prevalence of motor impairment in autism spectrum disorders. Brain Dev 29: 565-570.    
  • 7. Gillberg C, Steffenburg S, Jakobsson G (1987) Neurobiological findings in 20 relatively gifted children with Kanner-type autism or Asperger syndrome. Dev Med Child Neurol 29: 641-649.
  • 8. Khalfa S, Bruneau N, Roge B, et al. (2001) Peripheral auditory asymmetry in infantile autism. Eur J Neurosci 13: 628-632.    
  • 9. Boddaert N, Belin P, Chabane N, et al. (2003) Perception of complex sounds: abnormal pattern of cortical activation in autism. Am J Psychiatry 160: 2057-2060.    
  • 10. Boddaert N, Chabane N, Belin P, et al. (2004) Perception of complex sounds in autism: abnormal auditory cortical processing in children. Am J Psychiatry 161: 2117-2120.    
  • 11. Rosenhall U, Nordin V, Brantberg K, et al. (2003) Autism and auditory brain stem responses. Ear Hear 24: 206-214.
  • 12. Teder-Salejarvi WA, Pierce KL, Courchesne E, et al. (2005) Auditory spatial localization and attention deficits in autistic adults. Brain Res Cogn Brain Res 23: 221-234.
  • 13. Gomot M, Belmonte MK, Bullmore ET, et al. (2008) Brain hyper-reactivity to auditory novel targets in children with high-functioning autism. Brain 131: 2479-2488.    
  • 14. Demopoulos C, Brandes-Aitken AN, Desai SS, et al. (2015) Shared and divergent auditory and tactile processing in children with autism and children with sensory processing dysfunction relative to typically developing peers. J Int Neuropsychol Soc 21: 444-454.
  • 15. Huguet G, Ey E, Bourgeron T (2013) The genetic landscapes of autism spectrum disorders. Annu Rev Genomics Hum Genet 14: 191-213.    
  • 16. Jeste SS, Geschwind DH (2014) Disentangling the heterogeneity of autism spectrum disorder through genetic findings. Nat Rev Neurol 10: 74-81.    
  • 17. Bourgeron T (2015) From the genetic architecture to synaptic plasticity in autism spectrum disorders. Nat RevNeurosci 16: 551-563.
  • 18. Levitt P, State MW (2011) The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci 14: 1499-1506.    
  • 19. Rogers SJ, Ozonoff S (2005) Annotation: what do we know about sensory dysfunction in autism? A critical review of the empirical evidence. J Child Psychol Psychiatry 46: 1255-1268.
  • 20. Benítez-Burraco A, Lattanzi W, Murphy E (2016) Language Impairments in ASD Resulting from a Failed Domestication of the Human Brain. Front Neurosci 10: 373.
  • 21. Murphy E, Benítez-Burraco A (2016) Language deficits in schizophrenia and autism as related oscillatory connectomopathies: An evolutionary account. Neurosci Biobehav Rev: 044198.
  • 22. Cohly HH, Panja A (2005) Immunological findings in autism. Int Rev Neurobiol 71: 317-341.
  • 23. Ronald A, Hoekstra RA (2011) Autism spectrum disorders and autistic traits: a decade of new twin studies. Am J Med Genet B Neuropsychiatr Genet 156: 255-274.    
  • 24. Torres A, Phillips J, Miller J, et al. (2011) Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry 68: 1095-1102.    
  • 25. Atladóttir HO, Thorsen P, Østergaard L, et al. (2010) Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 40: 1423-1430.    
  • 26. Christensen J, Grønborg TK, Sørensen MJ, et al. (2013) Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309: 1696-1703.    
  • 27. LaSalle JM (2011) A genomic point-of-view on environmental factors influencing the human brain methylome. Epigenetics 6: 862-869.    
  • 28. Grafodatskaya D, Chung B, Szatmari P, et al. (2010) Autism spectrum disorders and epigenetics. J Am Acad Child Adolesc Psychiatry 49: 794-809.    
  • 29. Persico AM, Bourgeron T (2006) Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 29: 349-358.    
  • 30. Schanen NC (2006) Epigenetics of autism spectrum disorders. Hum Mol Genet 15: 138-150.    
  • 31. Hutnick LK, Golshani P, Namihira M, et al. (2009) DNA hypomethylation restricted to the murine forebrain induces cortical degeneration and impairs postnatal neuronal maturation. Hum Mol Genet 18: 2875-2888.    
  • 32. Feng S, Cokus SJ, Zhang X, et al. (2010) Conservation and divergence of methylation patterning in plants and animals. Proc Natl Acad Sci U S A 107: 8689-8694.    
  • 33. LaSalle JM (2013) Epigenomic strategies at the interface of genetic and environmental risk factors for autism. J Hum Genet 58: 396-401.    
  • 34. Millan MJ (2013) An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy. Neuropharmacology 68: 72-82.
  • 35. Ebert DH, Greenberg ME (2013) Activity-dependent neuronal signalling and autism spectrum disorder. Nature 493: 327-337.    
  • 36. Bestor TH, Tycko B (1996) Creation of genomic methylation patterns. Nat Genet 12: 363-367.    
  • 37. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16: 6-21.    
  • 38. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33: 245-254.    
  • 39. Li E, Bestor TH, Jaenisch R (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69: 915-926.    
  • 40. Lei H, Oh SP, Okano M, et al. (1996) De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122: 3195-3205.
  • 41. Okano M, Bell DW, Haber DA, et al. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257.    
  • 42. Dong E, Gavin DP, Chen Y, et al. (2012) Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients. Translational Psychiatry 2: e159.    
  • 43. Berko ER, Suzuki M, Beren F, et al. (2014) Mosaic epigenetic dysregulation of ectodermal cells in autism spectrum disorder. PLoS Genet 10: e1004402.    
  • 44. Ginsberg MR, Rubin RA, Falcone T, et al. (2012) Brain transcriptional and epigenetic associations with autism. PLoS One 7: e44736.    
  • 45. Ladd-Acosta C, Hansen KD, Briem E, et al. (2014) Common DNA methylation alterations in multiple brain regions in autism. Mol Psychiatry 19: 862-871.    
  • 46. Nardone S, Sharan Sams D, Reuveni E, et al. (2014) DNA methylation analysis of the autistic brain reveals multiple dysregulate biological pathways. Transl Psychiatry 4: e433.    
  • 47. Nguyen A, Rauch TA, Pfeifer GP, et al. (2010) Global methylation profiling of lymphoblastoid cell lines reveals epigenetic contributions to autism spectrum disorders and a novel autism candidate gene, RORA, whose protein product is reduced in autistic brain. FASEB J 24: 3036-3051.    
  • 48. Wong CC, Meaburn EL, Ronald A, et al. (2014) Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Mol Psychiatry 19: 495-503.    
  • 49. Wang Y, Fang Y, Zhang F, et al. (2014) Hypermethylation of the enolase gene (ENO2) in autism. Eur J Pediatr 173:1233-1244.    
  • 50. Keil KP, Lein PJ (2016) DNA methylation: a mechanism linking environmental chemical exposures to risk of autism spectrum disorders? Environ Epigenet 2: pii: dvv012.
  • 51. Feinberg JI, Bakulski KM, Jaffe AE, et al. (2015) Paternal sperm DNA methylation associated with early signs of autism risk in an autism-enriched cohort. Int J Epidemiol 44: 1199-1210.
  • 52. Amir RE, Van den Veyver IB, Wan M, et al. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188.    
  • 53. Hatton DD, Sideris J, Skinner M, et al. (2006) Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP. Am J Med Genet 140: 1804-1813.
  • 54. Iossifov I, O’roak BJ, Sanders SJ, et al. (2014) The contribution of de novo coding mutations to autism spectrum disorder. Nature 515: 216-221.    
  • 55. De Rubeis S, He X, Goldberg AP, et al. (2014) Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515: 209-215.    
  • 56. Vallianatos CN, Iwase S (2015) Disrupted intricacy of histone H3K4 methylation in neurodevelopmental disorders. Epigenomics 7: 503-519.    
  • 57. Thatcher KN, LaSalle JM (2006) Dynamic changes in Histone H3 lysine 9 acetylation localization patterns during neuronal maturation require MeCP2. Epigenetics 1: 24-31.
  • 58. Christianson AL, Chester N, Kromberg JG (1994) Fetal valproate syndrome: clinical and neuro‐developmental features in two sibling pairs. Dev Med Child Neurol 36: 361-369.
  • 59. Williams PG, Hersh JH. (1997) A male with fetal valproate syndrome and autism. Dev Med Child Neurol 39: 632-634.
  • 60. Williams G, King J, Cunningham M, et al. (2001) Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 43: 202-206.    
  • 61. Moore S, Turnpenny P, Quinn A, et al. (2000) A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 37: 489-497.    
  • 62. Tomasz Schneider RP (2004) Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacol 30: 80-89.
  • 63. Wagner GC, Reuhl KR, Cheh M, et al. (2006) A new neurobehavioral model of autism in mice: pre-and postnatal exposure to sodium valproate. J Autism Dev Disord 36: 779-793.    
  • 64. Guidotti A, Dong E, Kundakovic M, et al. (2009). Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol Sci 30: 55-60.    
  • 65. Kundakovic M, Chen Y, Guidotti A, et al. (2009) The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol Pharmacol 75: 342-354.    
  • 66. Tremolizzo L, Doueiri MS, Dong E, et al. (2005) Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry 57: 500-509.    
  • 67. Zhubi A, Chen Y, Dong E, et al. (2014) Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum. Transl Psychiatry 4: e349.    
  • 68. Flashner BM, Russo ME, Boileau JE, et al. (2013) Epigenetic factors and autism spectrum disorders. Neuromolecular Med 15: 339-350.    
  • 69. Jiang YH, Sahoo T, Michaelis RC, et al. (2004) A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet A 131: 1-10.


Reader Comments

your name: *   your email: *  

Copyright Info: 2016, Sraboni Chaudhury, licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Copyright © AIMS Press All Rights Reserved